Opportunity
SAM #SPE2DP26R0004
Solicitation for Injectable Egg-Free Influenza Vaccine for 2027-2028 Flu Season
Buyer
DLA Troop Support
Posted
September 24, 2026
Respond By
October 08, 2026
Identifier
SPE2DP26R0004
NAICS
325414, 325412
This opportunity from the Defense Logistics Agency (DLA) Troop Support Medical requests injectable egg-free influenza vaccine for the 2027-2028 flu season. - Government Buyer: - Defense Logistics Agency (DLA) Troop Support Medical, Philadelphia, PA - Products Requested: - Injectable egg-free influenza vaccine for adults (18+) - Estimated annual quantity: 300,000 doses - Guaranteed minimum: 75% of estimate; contract maximum: 150% of estimate - Must be FDA-approved and CDC ACIP recommended - Delivered in prefilled syringes - Formula determined by FDA Vaccines and Related Biological Products Advisory Committee - National Stock Numbers to be established at award - Delivery Requirements: - Delivery to Defense Depot New Cumberland, PA - Phased delivery schedule: 40% by first milestone, 25% by second, 25% by third, 10% by final - Unique Requirements: - Vaccine must be egg-free and suitable for adults - Indefinite quantity contract structure - No specific OEMs or part numbers named in solicitation - OEMs: - No OEMs specified; opportunity open to FDA-approved manufacturers of egg-free influenza vaccines
Description
The Defense Logistics Agency Troop Support is soliciting for the supply of Injectable Egg-Free Influenza Vaccine for the 2027-2028 flu season. Approximately 300,000 doses are included in this requirement. (Quantities may increase or decrease pending receipt of final Service requirements.) The vaccines shall be in prefilled syringes presentation. The vaccine shall be FDA-approved for immunizing individuals 18 years and older.
The formula for the 2027-2028 season shall be determined by the U.S. Food & Drug Administration (FDA) Vaccines and Related Biological Products Advisory Committee. Other specification data is included in the solicitation. Successful contractor must have FDA Approval, and the vaccine must be U.S. Centers for Disease Control and Prevention (CDC) Advisory Committee on Immunization Practices (ACIP) recommended. National Stock Numbers shall be established at the time of award. An indefinite quantity contract is proposed. The quantity indicated is an annual estimate only. The guaranteed minimum will be 75% of the annual estimate, and a contract maximum will be established at 150% of the annual estimate.
Ordered quantities shall be delivered to the Defense Depot New Cumberland, PA. The contractor shall be capable of delivering 40% of the requirement by August 12, 2027, 25% by August 26, 2027, 25% by September 9, 2027, and the residual 10% by September 23, 2027. The Delivery Schedule shall apply to the estimated annual quantity. This delivery schedule is the preferred delivery schedule. Other delivery schedules may be considered.
A copy of the solicitation will be posted to the DLA Bid Board System (DIBBS) at https://www.dibbs.bsm.dla.mil and SAM.gov at https://www.sam.gov. Interested parties should contact Rosbert Jones (445-737-1254) (Rosbert.Jones@dla.mil) for any questions/comments. Interested parties are further advised to set up automated notifications of presolicitation or solicitation changes through this website. The current projected solicitation date is October of 2026. DLA reserves the right to issue the solicitation before or after the projected solicitation date.